Remedium Capital Partners, LLC
CIK 0002104501
Annualised vol
22.328859%
Beta
0.155778
HHI
2415.34572
Top-10 weight
100.0%
VaR 95%
1.886971%
VaR 99%
4.523004%
Max drawdown
58.887321%
Matched value
82.757573%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
What the latest 13F shows bought and sold against the quarter before, by share count.
| Ticker | Change | Shares now | Shares before | Share change % | Value now ($) |
|---|---|---|---|---|---|
| ORKA | UNCHANGED | 1,565,661 | 1,565,661 | 0.0% | 149,003,957 |
| SYRE | ADDED | 1,464,169 | 1,456,231 | 0.55% | 129,988,924 |
| DMRA | UNCHANGED | 2,045,473 | 2,045,473 | 0.0% | 53,202,753 |
| JBIO | UNCHANGED | 1,577,750 | 1,577,750 | 0.0% | 35,057,605 |
| CBIO | UNCHANGED | 361,250 | 361,250 | 0.0% | 6,502,500 |
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| ORKA | UNCHANGED | Oruka Therapeutics Inc | COM | 687604108 | 149,003,957 | 32.99 | 1565661.0 |
| SYRE | ADDED | Spyre Therapeutics Inc | COM | 00773J202 | 129,988,924 | 28.78 | 1464169.0 |
| - | Apogee Therapeutics Inc | COM | 03770N101 | 77,871,496 | 17.24 | 586691.0 | |
| DMRA | UNCHANGED | Damora Therapeutics Inc | COM | 36322Q206 | 53,202,753 | 11.78 | 2045473.0 |
| JBIO | UNCHANGED | Jade Biosciences Inc | COM | 008064206 | 35,057,605 | 7.76 | 1577750.0 |
| CBIO | UNCHANGED | Crescent Biopharma Inc | COM | G2545C104 | 6,502,500 | 1.44 | 361250.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-07 | 451,627,235 | 6 | 22.328859 | 0.155778 | 58.887321 |
| 2026-03-31 | 2026-05-19 | 281,150,119 | 6 | 22.391265 | 0.158531 | 59.214017 |
| 2025-12-31 | 2026-02-12 | 170,211 | 6 | 19.044815 | 0.120172 | 50.617608 |